MarketIQ Analyst Report for Agape ATP Corporation Common Stock

NO. 17, 17-1, 17-2, 17-3, WISMA LAXTON,, JALAN DESA, TAMAN DESA, OFF JALAN KLANG, KUALA LUMPUR, MY
ATPC

Last Updated: 19 Sep 2024

Executive Summary

Agape ATP Corporation (ATPC) is a life sciences company that provides health services. The company has a market capitalization of $7.89 million and trades on the NASDAQ exchange. ATPC's latest stock price is $2.03.

Company Overview

Agape ATP Corporation was founded in 2002 and is headquartered in Kuala Lumpur, Malaysia. The company provides a range of health services, including: Clinical research
Medical device distribution
Healthcare consulting Agape ATP Corporation has operations in Malaysia, Singapore, Indonesia, and Thailand.

Fundamental Analysis

Agape ATP Corporation's financial performance has been mixed in recent years. The company has reported losses in each of the past three years. In 2023, the company reported a loss of $2.44 million on revenue of $13.78 million. Agape ATP Corporation's balance sheet is also weak. The company has more debt than equity and its current ratio is below 1.0.

Technical Analysis

Agape ATP Corporation's stock price has been in a downtrend since early 2023. The stock is currently trading below its 50-day and 200-day moving averages. The relative strength index (RSI) is also below 50, indicating that the stock is oversold.

Short Term Outlook

Agape ATP Corporation's stock price is likely to continue to decline in the short term. The company's financial performance is weak and the technical indicators are bearish.

Long Term Outlook

Agape ATP Corporation's long-term outlook is uncertain. The company's financial performance needs to improve and the technical indicators need to turn bullish before the stock can be considered a buy.

Analyst Recommendations

There are no analyst recommendations for Agape ATP Corporation.